ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Galapagos

Galapagos (GLPG)

26,78
-0,14
(-0,52%)
Fermé 11 Octobre 5:30PM

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
26,78
Prix Achat
26,70
Prix Vente
26,88
Volume échangé
51 196
26,68 Fourchette du Jour 27,12
22,00 Plage de 52 semaines 39,00
Cap du marché
Clôture Veille
26,92
Ouverture
26,86
Dernière Transaction
38
@
26.78
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
107 817
Actions en circulation
65 897 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
8,34
Bénéfice par action (BPA)
3,21
Chiffre d'affairess
843,8M
Bénéfice net
211,7M

À propos de Galapagos

Secteur
Coml Physical, Biologcl Resh
Industrie
Coml Physical, Biologcl Resh
Site Web
Siège social
Mechelen, Antwerp, Bel
Fondé
-
Galapagos est coté dans le secteur Coml Physical, Biologcl Resh de la Euronext avec le ticker GLPG. Le dernier cours de clôture d'Galapagos était de 26,92 €. Au cours de la dernière année, les actions de Galapagos ont été négociées dans une fourchette de prix de 22,00 € à 39,00 €.

Galapagos compte actuellement 65 897 000 actions en circulation. La capitalisation boursière d'Galapagos est de 1,77 € milliard. Galapagos a un ratio cours/bénéfice (ratio PE) de 8.34.

GLPG Dernières nouvelles

Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth

Mechelen, Belgium; October 7, 2024, 07:00 CET — Galapagos NV (Euronext & NASDAQ: GLPG), today announced the appointment by way of co-optation of Oleg Nodelman as Non-Executive Non-Independent...

Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth

Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth Mechelen, Belgium; October 7, 2024, 07:00 CET — Galapagos NV (Euronext & NASDAQ: GLPG), today announced...

Galapagos receives transparency notification from EcoR1 Capital

Galapagos receives transparency notification from EcoR1 Capital Mechelen, Belgium; 30 September 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a...

Galapagos receives transparency notification from EcoR1 Capital

Mechelen, Belgium; 30 September 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from EcoR1 Capital LLC. Pursuant to Belgian...

Galapagos receives transparency notification from EcoR1 Capital

Galapagos receives transparency notification from EcoR1 Capital Mechelen, Belgium; 16 September 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a...

Galapagos receives transparency notification from EcoR1 Capital

Mechelen, Belgium; 16 September 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from EcoR1 Capital LLC. Pursuant to Belgian...

Galapagos receives transparency notification from FMR LLC

Mechelen, Belgium; 3 September 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from FMR LLC. Pursuant to Belgian...

Galapagos receives transparency notification from FMR LLC

Galapagos receives transparency notification from FMR LLC Mechelen, Belgium; 3 September 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency...

Galapagos announces FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma

Galapagos announces FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma Mechelen, Belgium; August 23, 2024, 07:00...

Galapagos announces FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma

Mechelen, Belgium; August 23, 2024, 07:00 CET; regulated information – inside information – Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the U.S. Food and Drug Administration...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
11.044.040404040425.7427.8425.389691727.06526895DE
40.481.8250950570326.327.8425.389402526.6466572DE
121.967.8968573730924.8227.842210781725.33578619DE
26-2.34-8.0357142857129.1229.3229365625.51275077DE
52-6.32-19.093655589133.139228989629.49512722DE
156-16.435-38.030776350843.21566.282217756443.680799DE
260-115.22-81.1408450704142252.92230705197.99854372DE

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
AGILAgility Real Estate Inc
US$ 2,60
(30,00%)
1,14k
ALACTActicor Biotech
0,53 €
(25,30%)
223,46k
GNROGeNeuro SA
0,089 €
(21,25%)
48,7k
ALDOLDolfines
0,0007 €
(16,67%)
46,91M
NHOANHOA
1,254 €
(16,33%)
1,01M
INAInapa Inv Part Gestao
0,0092 €
(-34,29%)
7,47M
MLUMGUmalis Group
1,45 €
(-25,64%)
7
ALAVEAventador
0,0014 €
(-22,22%)
32,12M
ALGAUGaussin
0,0377 €
(-18,04%)
496,12k
ALSRSSirius Media
0,027 €
(-15,63%)
430,1k
BCPBanco Comercial Portugues SA
0,4186 €
(0,50%)
67,86M
ALDOLDolfines
0,0007 €
(16,67%)
46,91M
ALAVEAventador
0,0014 €
(-22,22%)
32,12M
ALNEVNeovacs
0,0004 €
(0,00%)
21,5M
ALHPIHopium SA
0,0165 €
(-0,60%)
21,34M

Dernières Valeurs Consultées

Delayed Upgrade Clock